UB Paderborn / Katalog / Suche / in CDI

1 – 19 von 19

Sortiert nach

Pharmacokinetics of Ganciclovir during Continuous Venovenous Hemodiafiltration in Critically Ill Patients

Antimicrobial Agents and Chemotherapy, 2014-01, Vol.58 (1), p.94-101

2014

Volltextzugriff (PDF)

Clinical Pharmacokinetic and Pharmacodynamic Profile of Vericiguat

Clinical pharmacokinetics, 2024-06, Vol.63 (6), p.751-771

2024

Volltextzugriff (PDF)

Pharmacometric approaches for linking pharmacokinetic and pharmacodynamic models of sunitinib and pazopanib with clinical outcome

Fritsch, Achim

2018

Volltextzugriff (PDF)

A prospective, multi-center study of individualized, pharmacokinetically (PK)-guided dosing of 5-fluorouracil (5-FU) in metastatic colorectal cancer (mCRC) patients treated with weekly or biweekly 5-FU/oxaliplatin containing regimens

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.3542-3542

2015

Volltextzugriff (PDF)

Pharmacokinetics of Ganciclovir during Continuous Venovenous Hemodiaifltration in Critically Ill Patients

Antimicrobial agents and chemotherapy, 2014, Vol.58 (1), p.94-101

2014

Volltextzugriff (PDF)

Description of the EuroTARGET cohort: A European collaborative project on TArgeted therapy in renal cell cancer—GEnetic- and tumor-related biomarkers for response and toxicity

Urologic oncology, 2017-08, Vol.35 (8), p.529.e9-529.e16

2017

Volltextzugriff (PDF)

Inhibition of ADAM17 impairs endothelial cell necroptosis and blocks metastasis

The Journal of experimental medicine, 2022-01, Vol.219 (1)

2022

Volltextzugriff (PDF)

Hypercapnic Failure in Acute Exacerbated COPD Patients: Severe Airflow Limitation as an Early Warning Signal

Journal of clinical medicine, 2022-12, Vol.12 (1), p.258

2022

Volltextzugriff (PDF)

ROS1 genomic rearrangements are rare actionable drivers in microsatellite stable colorectal cancer

International journal of cancer, 2022-12, Vol.151 (12), p.2161-2171

2022

Volltextzugriff (PDF)

ÖGARI Ethik-Manifest für eine menschlichere Medizin

Wiener medizinische Wochenschrift, 2019-11, Vol.169 (15-16), p.364-366

2019

Volltextzugriff (PDF)

ErtlFunctionalGroupsFinder: automated rule-based functional group detection with the Chemistry Development Kit (CDK)

Journal of cheminformatics, 2019-06, Vol.11 (1), p.37-8, Article 37

2019

Volltextzugriff (PDF)

Wiener medizinische Wochenschrift (1946)

Wiener medizinische Wochenschrift, 2019-11, Vol.169 (15-16), p.364-366

2019

Volltextzugriff (PDF)

Frequency, molecular characteristics, and therapeutic targeting of ROS1 oncogenic fusions in colorectal cancer

Journal of clinical oncology, 2022-02, Vol.40 (4_suppl), p.160-160

2022

Volltextzugriff (PDF)

Targeting Secondary and Tertiary Resistance to BRAF Inhibition in BRAF V600E-Mutated Metastatic Colorectal Cancer

JCO precision oncology, 2021-11, Vol.5, p.1082

2021

Volltextzugriff (PDF)

Paraplegia in a Bornean orangutan (Pongo pygmaeus pygmaeus) due to multiple myeloma

Journal of medical primatology, 2009-10, Vol.38 (5), p.335-339

2009

Volltextzugriff (PDF)

FLT3-ITD but Not FLT3-TKD Mutations Have Major Prognostic Impact in Normal Karyotype AML

Blood, 2007-11, Vol.110 (11), p.3486-3486

2007

Volltextzugriff (PDF)

NPM-1, but Not FLT3-ITD Mutations Predict Early Blast Cell Clearance and CR Rate in Patients with Normal Karyotype AML or High-Risk Myelodysplastic Syndrome (MDS)

Blood, 2006-11, Vol.108 (11), p.805-805

2006

Volltextzugriff (PDF)

1 – 19 von 19

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(18)
Mit Volltextzugriff
(17)

Publikationsform

Artikel
(18)
Dissertationen
(1)

Sprache

Englisch
(17)
Deutsch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(11)
Life Sciences & Biomedicine
(10)
Humans
(6)
Male
(4)
Oncology
(4)
Software
(3)
Adult
(2)
Aged
(2)
Animals
(2)
Antineoplastic Agents - Pharmacology
(2)
Antineoplastic Agents - Therapeutic Use
(2)
Biological And Medical Sciences
(2)
Biomarkers
(2)
Colorectal Neoplasms - Drug Therapy
(2)
Colorectal Neoplasms - Genetics
(2)
Drug Dosages
(2)
Female
(2)
Genomics
(2)
Internal Medicine
(2)
Medical Sciences
(2)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Pharmacokinetics of Ganciclovir during Continuous Venovenous Hemodiafiltration in Critically Ill Patients

Genome-Wide Meta-Analysis Identifies Variants in DSCAM and PDLIM3 That Correlate with Efficacy Outcomes in Metastatic Renal Cell Carcinoma Patients Treated with Sunitinib

Clinical Pharmacokinetic and Pharmacodynamic Profile of Vericiguat

Pharmacometric approaches for linking pharmacokinetic and pharmacodynamic models of sunitinib and pazopanib with clinical outcome

A prospective, multi-center study of individualized, pharmacokinetically (PK)-guided dosing of 5-fluorouracil (5-FU) in metastatic colorectal cancer (mCRC) patients treated with weekly or biweekly 5-FU/oxaliplatin containing regimens

Pharmacokinetics of Ganciclovir during Continuous Venovenous Hemodiaifltration in Critically Ill Patients

Description of the EuroTARGET cohort: A European collaborative project on TArgeted therapy in renal cell cancer—GEnetic- and tumor-related biomarkers for response and toxicity

Inhibition of ADAM17 impairs endothelial cell necroptosis and blocks metastasis

Hypercapnic Failure in Acute Exacerbated COPD Patients: Severe Airflow Limitation as an Early Warning Signal

ROS1 genomic rearrangements are rare actionable drivers in microsatellite stable colorectal cancer

ÖGARI Ethik-Manifest für eine menschlichere Medizin

ErtlFunctionalGroupsFinder: automated rule-based functional group detection with the Chemistry Development Kit (CDK)

Wiener medizinische Wochenschrift (1946)

Frequency, molecular characteristics, and therapeutic targeting of ROS1 oncogenic fusions in colorectal cancer

Targeting Secondary and Tertiary Resistance to BRAF Inhibition in BRAF V600E-Mutated Metastatic Colorectal Cancer

NPM1 but not FLT3-ITD mutations predict early blast cell clearance and CR rate in patients with normal karyotype AML (NK-AML) or high-risk myelodysplastic syndrome (MDS)

Paraplegia in a Bornean orangutan (Pongo pygmaeus pygmaeus) due to multiple myeloma

FLT3-ITD but Not FLT3-TKD Mutations Have Major Prognostic Impact in Normal Karyotype AML

NPM-1, but Not FLT3-ITD Mutations Predict Early Blast Cell Clearance and CR Rate in Patients with Normal Karyotype AML or High-Risk Myelodysplastic Syndrome (MDS)

Suchergebnisse filtern